Allergic Conjunctivitis – Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Aldeyra Therapeutics, Inc., Allakos, Inc., Inmunotek, Regeneron Pharmaceuticals
As per Global Insight services’ assessment, about 6 prominent pharma and biotech giants are working on 6 drugs in the Allergic Conjunctivitis – pipeline landscape …
